NA 3 glycan: a potential therapy for retinal pigment epithelial deficiency

Atrophic age‐related macular degeneration ( AMD ) is the most common type of AMD , yet there is no United States Food and Drug Administration ( FDA )‐approved therapy. This disease is characterized by retinal pigment epithelial ( RPE ) insufficiency, primarily in the macula, which affects the struct...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The FEBS journal 2019-12, Vol.286 (24), p.4876-4888
Hauptverfasser:	Chintalapudi, Sumana R., Wang, XiangDi, Wang, XiaoFei, Shi, Yunfeng, Kocak, Mehmet, Palamoor, Mallika, Davis, Raven N., Hollingsworth, T. J., Jablonski, Monica M.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!